Navigation Links
Ekkyo Presents a Positive Assessment one Year After the Launch of EkkyLite(TM), its New Scar Healing System
Date:10/8/2009

MARSEILLE, France, October 8 /PRNewswire/ -- Ekkyo(TM), a photomedicine company that develops first-in-class laser-based systems for skin scar prevention and reduction is presenting today, one year after the commercial launch of EkkyLite(TM), its assessment through some key figures:

    - More than 50 French surgeons have used the EkkyLite(TM) system
    - Almost 200 patients have been treated during surgical operations,
      directly in the operating room
    - 10 French centres are already equipped with the EkkyLite(TM) laser,
      allowing coverage of the main regions in France
    - 8 foreign countries are now working with EkkyLite(TM) through a network
      of distributors

Ekkyo has also set up a national register to log and measure the development of the healing process for each patient treated. This confidential register provides personalised access for each practitioner equipped with an EkkyLite (TM) system, allowing them to register the patients treated and also giving them the possibility of publishing scientific articles related to the results obtained.

"This register is a genuine multicentre database updated in real time," comments Alain Cornil, Ekkyo's CEO.

"The development of EkkyLite(TM), both in France and abroad, confirms the potential of our approach and allows us, in return, to enrich our clinical database," adds Cornil "Thanks to this enlarged palette of users, we will very soon be able to present new clinical results."

In the final quarter of 2009, Ekkyo continues to progress and will present EkkyLite(TM) at a national level and, thanks to its network of distributors at an international level, at the following conventions: 10 October: EkkyLite(TM) will be represented by the Austrian distributor, STRADIS, at a convention organised by Austrian Plastic Surgery Society. Alexandre Capon, reference surgeon, will also speak on the LASH (Laser Assisted Skin Healing) technique during the lunch symposia. 16 October: Portuguese plastic surgery convention in Lisbon. From the 23 to the 27 October: plastic surgery 2009 in Seattle. An international convention bringing together more than 3000 surgeons from all over the world. From the 23 to the 25 November: An undisputed name in the world of plastic surgery, the Societe Francaise de Chirurgie Plastique, Reparatrice et Esthetique (SOFCPRE - French Society of Plastic, Reconstructive and Aesthetic Surgery) is organising its 54th convention this year at the CNIT in Paris. The Ekkyo team will be present on stand number 29 and will have the opportunity to officially announce the results of the clinical study carried out since 2007.

About Ekkyo

Created in 2006, Ekkyo is a photomedicine company that develops and markets first-in-class scar-healing devices to reduce scarring and improve post-surgical comfort.

The first laser-assisted skin healing system and the first product marketed by the company, EkkyLite(TM) assists the surgeon right after the critical moment of wound closure, at the early stage of the skin-healing process. By applying a precisely controlled heat stress early in the inflammatory phase of the skin healing process, EkkyLite(TM) makes possible to stimulate and accurately control the balance between skin repair and regeneration. Results confirm the benefits if this LASH(R) (Laser Assisted Skin Healing) technology: enhanced healing with a significantly reduced scar thus repaired tissue is similar to normal skin in its structure.

By this new approach Ekkyo's ambition is to make laser technology available to all, to surgeons first and tomorrow to all doctors facing skin healing issues, and so to contribute to improve the comfort of the intervention and the quality of life of the 70 million patients who are confronted every year to problems of skin healing.

Based in Aix en Provence, France, Ekkyo has 20 staff members as of September 2009.

More on http://www.ekkyo.com

SOURCE Ekkyo


'/>"/>
SOURCE Ekkyo
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine"
2. InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study of Diabetes Meeting
3. Strativa Pharmaceuticals Development Partner, BioAlliance Pharma, Presents Phase III Study Results of Miconazole Lauriad(R) for the Treatment of Oropharyngeal Candidiasis
4. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
5. NexBio(R) Presents DAS181 (Fludase(R)*) Potently Inhibits Novel Swine-Origin A(H1N1) and NAI-Resistant Influenza Viruses, at ICAAC 2009
6. Curemark CEO Presents at Epigenomics Conference
7. Neurocrine Biosciences Presents Elagolix Data
8. Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association
9. Micromet Presents Update on Blinatumomabs Response Rate and Duration in a Phase 1 Study in Non-Hodgkins Lymphoma Patients
10. Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting
11. Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb 24, 2017 Research and Markets has ... Strategies - 2016" report to their offering. ... The latest research Dry eye Drugs Price Analysis ... global Dry eye market. The research answers the following questions: ... eye and their clinical attributes? How are they positioned in the Global ...
(Date:2/24/2017)... 24, 2017  In conjunction with DURECT Corporation,s (Nasdaq: ... press release, you are invited to listen to a ... internet on Tuesday, March 14, 2017 at 4:30 pm ... live audio webcast of the presentation will be available ... clicking "Investor Relations."  If you are unable to participate ...
(Date:2/24/2017)... , Feb. 24, 2017 Juan ... & Associates PC , a boutique securities firm headquartered ... York City , announces that a class action ... Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ: ... the Company,s securities between July 23, 2015 and December 30, ...
Breaking Medicine Technology:
(Date:2/23/2017)... , ... February 23, 2017 , ... ... of Justice jointly issued a letter to withdraw previous guidance issued ... their gender identity. The guidance issued in May 2016 by the Obama Administration ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease Report®, ... be participating in Rare Disease Day events, hosted by the Rare Disease Legislative ... Report, a website, weekly e-newsletter and quarterly publication, will be conducting interviews with ...
(Date:2/23/2017)... Hollywood, CA (PRWEB) , ... February 23, 2017 , ... ... pleased to announce that they are sponsoring a raffle. Throughout the month of February, ... Winners will receive a gift card for a dinner for two at the Cheesecake ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... will host a diverse symposium on “Doping in Sport: How the Culture ... Mullin Richter & Hampton LLP. The symposium will be held at Pepperdine University ...
(Date:2/23/2017)... ... February 23, 2017 , ... ERT, a ... today announced that Premier Research, a leading clinical development service provider, has selected ... becoming increasingly complex, due in part to an array of circumstances including the ...
Breaking Medicine News(10 mins):